Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma
Congcong Zhang, Michael C. Burger, Lukas Jennewein, et al.
JNCI Journal of the National Cancer Institute (2015) Vol. 108, Iss. 5
Open Access | Times Cited: 346

Showing 1-25 of 346 citing articles:

Targeting natural killer cells in cancer immunotherapy
Camille Guillerey, Nicholas D. Huntington, Mark J. Smyth
Nature Immunology (2016) Vol. 17, Iss. 9, pp. 1025-1036
Closed Access | Times Cited: 977
The Molecular Mechanism of Natural Killer Cells Function and Its Importance in Cancer Immunotherapy
Sourav Paul, Girdhari Lal
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 655
NK cell-based cancer immunotherapy: from basic biology to clinical development
Sizhe Liu, Vasiliy Galat, Yekaterina Galat, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 488
First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia.
Xiaowen Tang, Lin Yang, Zheng Li, et al.
PubMed (2018) Vol. 8, Iss. 6, pp. 1083-1089
Closed Access | Times Cited: 369
Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors
Ombretta Melaiu, Valeria Lucarini, Loredana Cifaldi, et al.
Frontiers in Immunology (2020) Vol. 10
Open Access | Times Cited: 333
Targeting cellular pathways in glioblastoma multiforme
Joshua R. D. Pearson, Tarik Regad
Signal Transduction and Targeted Therapy (2017) Vol. 2, Iss. 1
Open Access | Times Cited: 307
Current State of Immunotherapy for Treatment of Glioblastoma
Tresa McGranahan, Kate E. Therkelsen, Sarah Ahmad, et al.
Current Treatment Options in Oncology (2019) Vol. 20, Iss. 3
Open Access | Times Cited: 277
Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity
Congcong Zhang, Pranav Oberoi, Sarah Oelsner, et al.
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 275
3D model for CAR ‐mediated cytotoxicity using patient‐derived colorectal cancer organoids
Theresa Schnalzger, Marnix HP de Groot, Congcong Zhang, et al.
The EMBO Journal (2019) Vol. 38, Iss. 12
Open Access | Times Cited: 264
CAR T-cell therapy for glioblastoma: recent clinical advances and future challenges
Stephen Bagley, Arati Desai, Gerald P. Linette, et al.
Neuro-Oncology (2018) Vol. 20, Iss. 11, pp. 1429-1438
Open Access | Times Cited: 260
Immunotherapy: Reshape the Tumor Immune Microenvironment
Bingzhe LV, Yunpeng Wang, Dongjiang Ma, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 253
NKG2D-Based CAR T Cells and Radiotherapy Exert Synergistic Efficacy in Glioblastoma
Tobias Weiß, Michael Weller, Matthias Gückenberger, et al.
Cancer Research (2017) Vol. 78, Iss. 4, pp. 1031-1043
Open Access | Times Cited: 241
Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer
Rohtesh S. Mehta, Katayoun Rezvani
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 232
Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysis
Nicholas A. Vitanza, Adam Johnson, Ashley Wilson, et al.
Nature Medicine (2021) Vol. 27, Iss. 9, pp. 1544-1552
Closed Access | Times Cited: 217
Current status and perspective of CAR-T and CAR-NK cell therapy trials in Germany
Nawid Albinger, Jessica Hartmann, Evelyn Ullrich
Gene Therapy (2021) Vol. 28, Iss. 9, pp. 513-527
Open Access | Times Cited: 196
Harnessing the immune system in glioblastoma
Nicholas F. Brown, Thomas J. Carter, Diego Ottaviani, et al.
British Journal of Cancer (2018) Vol. 119, Iss. 10, pp. 1171-1181
Open Access | Times Cited: 192
NK cells and ILCs in tumor immunotherapy
Simona Sivori, Daniela Pende, Linda Quatrini, et al.
Molecular Aspects of Medicine (2020) Vol. 80, pp. 100870-100870
Open Access | Times Cited: 191
CAR-NK for tumor immunotherapy: Clinical transformation and future prospects
Wenxiu Wang, Jingting Jiang, Changping Wu
Cancer Letters (2019) Vol. 472, pp. 175-180
Open Access | Times Cited: 190
CAR T Cells for Acute Myeloid Leukemia: State of the Art and Future Directions
Sherly Mardiana, Saar Gill
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 182
CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools for Cancer Immunotherapy
Michael C. Burger, Congcong Zhang, Patrick N. Harter, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 175
Continuously expanding CAR NK-92 cells display selective cytotoxicity against B-cell leukemia and lymphoma
Sarah Oelsner, Miriam E. Friede, Congcong Zhang, et al.
Cytotherapy (2016) Vol. 19, Iss. 2, pp. 235-249
Open Access | Times Cited: 169
Immunotherapy for Glioblastoma: Current Progress and Challenges
Miranda W. Yu, Daniela F. Quail
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 152
Overcoming Resistance to Natural Killer Cell Based Immunotherapies for Solid Tumors
Gaurav Nayyar, Yaya Chu, Mitchell S. Cairo
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 146
Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy
Ahmet Yılmaz, Hanwei Cui, Michael A. Caligiuri, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 145
CAR-NK cells for cancer immunotherapy: from bench to bedside
Leisheng Zhang, Meng Yuan, Xiaoming Feng, et al.
Biomarker Research (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 128
Page 1 - Next Page

Scroll to top